journal article·2026-05-20Open access

SIRT6‐Mediated Deacetylation of ATF3 Promotes Silica‐Induced Lung Fibrosis by Enhancing its Nuclear Import via Binding to Importin α

Demin Cheng, Wenxia Bu, Fengxu Wang, Yueyuan Jin, Rongzhu Liu, Rui Zhao, Xuehai Wang, Mengna Jiang, Jinping Shen, Xinhang Cheng, Zuming Chen, Li Zhu, Jinlong Li, Zhenzhong Ge, Shichen Miao, Haotian Xu, Xiaoyu Zhou, Dongming Wang, Xinyuan Zhao

Abstract

ABSTRACT Silicosis is the most common occupational lung disease caused by respirable crystalline silica inhalation, with limited therapeutic options. Cellular senescence plays a critical role in the pathogenesis of lung diseases, while the role of senescent macrophages in silicosis remains unclear. Single‐cell RNA sequencing (scRNA‐seq) of healthy and silicosis human and mouse lung tissues revealed that activating transcription factor 3 (ATF3)‐mediated macrophage senescence is closely linked to silicosis progression. Mechanistically, Sirtuin 6 (SIRT6)‐mediated ATF3 deacetylation enhanced its nuclear transport and subsequently activated mitochondria‐localized glutamic acid‐rich protein (MGARP) transcription, thereby causing mitochondrial dysfunction and macrophage senescence. Senescent macrophages promoted fibroblast activation via the secreted phosphoprotein 1 (SPP1)‐cluster of differentiation 44 (CD44) signaling pathway. Furthermore, the nuclear transport protein importin α and the molecular chaperone protein heat shock protein 70 (HSP70) competitively bound to ATF3, preventing its lysosomal degradation while promoting its nuclear import during macrophage senescence. Moreover, the small‐molecule inhibitor Itraconazole, which targets the binding site of ATF3 and importin α, could reduce ATF3 nuclear entry, macrophage senescence, and pulmonary fibrosis (PF). Collectively, our study provided insights into the mechanism by which deacetylated ATF3 facilitates silicosis progression via increased nuclear transport and macrophage senescence, and indicated potential therapeutic targets for PF.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Telomeres, Telomerase, and Senescence · Nuclear Structure and Function · Occupational and environmental lung diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Respiratory and Critical Care Medicine Affiliated Hospital of Nantong University School of Public Health Nantong University Nantong China

Department of Respiratory Wuxi No 8 People's Hospital Wuxi Jiangsu China

School of Public Health North China University of Science and Technology Tangshan Hebei China

Department of Breast Surgery Shanghai Key Laboratory of Maternal Fetal Medicine Shanghai Institute of Maternal‐Fetal Medicine and Gynecologic Oncology Shanghai First Maternity and Infant Hospital School of Medicine Tongji University Shanghai China

Department of Occupational & Environmental Health School of Public Health Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China

Key Laboratory of Environment and Health Ministry of Education & Ministry of Environmental Protection and State Key Laboratory of Environmental Health (Incubating) School of Public Health Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China

Funding

National Natural Science Foundation of China

References (70)

Show source-provided references
1. 10.1038/s41423‐025‐01288‐510.1038/s41423‐025‐01288‐5 ↗
2. 10.1016/j.jhazmat.2025.13879110.1016/j.jhazmat.2025.138791 ↗
3. 10.1038/s41467‐024‐54174‐510.1038/s41467‐024‐54174‐5 ↗
4. 10.1136/oemed‐2018‐10543610.1136/oemed‐2018‐105436 ↗
5. 10.1007/s00204‐024‐03795‐210.1007/s00204‐024‐03795‐2 ↗
6. 10.1007/s00204‐024‐03734‐110.1007/s00204‐024‐03734‐1 ↗
7. 10.1002/mdr2.7002010.1002/mdr2.70020 ↗
8. 10.1038/s41375‐022‐01686‐y10.1038/s41375‐022‐01686‐y ↗
9. 10.1172/jci15181710.1172/jci151817 ↗
10. 10.1016/j.cell.2023.08.00310.1016/j.cell.2023.08.003 ↗
11. 10.1016/j.intimp.2023.11052210.1016/j.intimp.2023.110522 ↗
12. 10.1038/s41419‐022‐04972‐w10.1038/s41419‐022‐04972‐w ↗
13. 10.1002/advs.20210412810.1002/advs.202104128 ↗
14. 10.1002/advs.20250195610.1002/advs.202501956 ↗
15. 10.1016/j.redox.2024.10322410.1016/j.redox.2024.103224 ↗
16. 10.1038/s41467‐020‐20540‐210.1038/s41467‐020‐20540‐2 ↗
17. 10.1016/j.pharmthera.2025.10890610.1016/j.pharmthera.2025.108906 ↗
18. 10.1002/mco2.34610.1002/mco2.346 ↗
19. 10.1186/s13073‐025‐01520‐x10.1186/s13073‐025‐01520‐x ↗
20. 10.1016/j.apsb.2024.01.00810.1016/j.apsb.2024.01.008 ↗
21. 10.1038/s41467‐025‐56402‐y10.1038/s41467‐025‐56402‐y ↗
22. 10.3390/biom1204059810.3390/biom12040598 ↗
23. 10.1002/advs.20241436710.1002/advs.202414367 ↗
24. 10.1016/j.ccell.2018.06.00210.1016/j.ccell.2018.06.002 ↗
25. 10.1016/j.semcancer.2014.03.00510.1016/j.semcancer.2014.03.005 ↗
26. 10.1038/s41388‐021‐01949‐510.1038/s41388‐021‐01949‐5 ↗
27. 10.7150/ijbs.1383310.7150/ijbs.13833 ↗
28. 10.1158/0008‐5472.Can‐23‐325010.1158/0008‐5472.Can‐23‐3250 ↗
29. 10.1038/s41586‐024‐07487‐w10.1038/s41586‐024‐07487‐w ↗
30. 10.1016/j.ymthe.2023.11.00210.1016/j.ymthe.2023.11.002 ↗
31. 10.1038/s41467‐019‐12001‐210.1038/s41467‐019‐12001‐2 ↗
32. 10.1073/pnas.191437611710.1073/pnas.1914376117 ↗
33. 10.1016/j.jhazmat.2023.13273310.1016/j.jhazmat.2023.132733 ↗
34. 10.1128/spectrum.01451‐2210.1128/spectrum.01451‐22 ↗
35. 10.1016/j.bcp.2025.11735910.1016/j.bcp.2025.117359 ↗
36. 10.1016/j.phymed.2022.15401710.1016/j.phymed.2022.154017 ↗
37. 10.1016/j.phymed.2025.15671410.1016/j.phymed.2025.156714 ↗
38. 10.1016/j.ecoenv.2025.11791710.1016/j.ecoenv.2025.117917 ↗
39. 10.1016/j.jhazmat.2025.13760510.1016/j.jhazmat.2025.137605 ↗
40. 10.3389/fphar.2022.91202910.3389/fphar.2022.912029 ↗
41. 10.1172/jci3243010.1172/jci32430 ↗
42. 10.1111/acel.1303210.1111/acel.13032 ↗
43. 10.1111/acel.1235010.1111/acel.12350 ↗
44. 10.1002/hep.2609910.1002/hep.26099 ↗
45. 10.4049/jimmunol.110218810.4049/jimmunol.1102188 ↗
46. 10.1038/s41590‐018‐0255‐310.1038/s41590‐018‐0255‐3 ↗
47. 10.1038/s41420‐021‐00797‐210.1038/s41420‐021‐00797‐2 ↗
48. 10.1038/s41419‐025‐07461‐y10.1038/s41419‐025‐07461‐y ↗
49. 10.1038/s41418‐019‐0380‐z10.1038/s41418‐019‐0380‐z ↗
50. 10.1161/circresaha.124.32432310.1161/circresaha.124.324323 ↗
51. 10.1080/15548627.2022.204644810.1080/15548627.2022.2046448 ↗
52. 10.1111/acel.1272010.1111/acel.12720 ↗
53. 10.1002/advs.20250224910.1002/advs.202502249 ↗
54. 10.1007/s12035‐013‐8602‐810.1007/s12035‐013‐8602‐8 ↗
55. 10.1016/j.cell.2022.11.00110.1016/j.cell.2022.11.001 ↗
56. 10.1093/procel/pwae05210.1093/procel/pwae052 ↗
57. 10.1016/j.pharmthera.2025.10890810.1016/j.pharmthera.2025.108908 ↗
58. 10.3390/biomedicines1101008810.3390/biomedicines11010088 ↗
59. 10.1007/s13238‐015‐0204‐y10.1007/s13238‐015‐0204‐y ↗
60. 10.1096/fj.202501210R10.1096/fj.202501210R ↗
61. 10.1093/neuonc/noad23210.1093/neuonc/noad232 ↗
62. 10.1172/jci8857410.1172/jci88574 ↗
63. 10.1016/j.jbc.2025.11051610.1016/j.jbc.2025.110516 ↗
64. 10.1073/pnas.241479012210.1073/pnas.2414790122 ↗
65. 10.1126/science.adp364510.1126/science.adp3645 ↗
66. 10.1186/s13045‐025‐01680‐810.1186/s13045‐025‐01680‐8 ↗
67. 10.1038/s41467‐025‐62288‐710.1038/s41467‐025‐62288‐7 ↗
68. 10.1016/j.ebiom.2021.10328810.1016/j.ebiom.2021.103288 ↗
69. 10.1002/advs.20240941610.1002/advs.202409416 ↗
70. 10.1186/s12967‐024‐05895‐010.1186/s12967‐024‐05895‐0 ↗